Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement
- PMID: 37338866
- DOI: 10.1001/jama.2023.9301
Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Anxiety disorders are commonly occurring mental health conditions. They are often unrecognized in primary care settings and substantial delays in treatment initiation occur.
Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in asymptomatic adults.
Population: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older.
Evidence assessment: The USPSTF concludes with moderate certainty that screening for anxiety disorders in adults, including pregnant and postpartum persons, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety disorders in older adults.
Recommendation: The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults. (I statement).
Comment in
-
Are There Reasons to Fear Anxiety Screening?JAMA. 2023 Jun 27;329(24):2132-2134. doi: 10.1001/jama.2023.7239. JAMA. 2023. PMID: 37338897 No abstract available.
-
Research and Professional Literature to Inform Practice, September/October 2023.J Midwifery Womens Health. 2023 Sep-Oct;68(5):659-664. doi: 10.1111/jmwh.13559. Epub 2023 Sep 14. J Midwifery Womens Health. 2023. PMID: 37708217 No abstract available.
Summary for patients in
-
Screening for Anxiety Disorders in Adults.JAMA. 2023 Jun 27;329(24):2202. doi: 10.1001/jama.2023.9446. JAMA. 2023. PMID: 37338867
Similar articles
-
Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2023 Jun 20;329(23):2057-2067. doi: 10.1001/jama.2023.9297. JAMA. 2023. PMID: 37338872
-
Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.JAMA. 2021 Sep 14;326(10):949-956. doi: 10.1001/jama.2021.14081. JAMA. 2021. PMID: 34519796
-
Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.JAMA. 2021 Jan 19;325(3):265-279. doi: 10.1001/jama.2020.25019. JAMA. 2021. PMID: 33464343
-
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044. JAMA. 2022. PMID: 35997723 Review.
-
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Jun 21;327(23):2326-2333. doi: 10.1001/jama.2022.8970. JAMA. 2022. PMID: 35727271 Review.
Cited by
-
Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017-2023.Front Psychiatry. 2024 Nov 1;15:1442490. doi: 10.3389/fpsyt.2024.1442490. eCollection 2024. Front Psychiatry. 2024. PMID: 39575192 Free PMC article.
-
The case for eliminating excessive worry as a requirement for generalized anxiety disorder: a cross-national investigation.Psychol Med. 2024 Oct 4;54(12):1-12. doi: 10.1017/S003329172400182X. Online ahead of print. Psychol Med. 2024. PMID: 39364896 Free PMC article.
-
Evaluating mental health support by healthcare providers for patients with atopic dermatitis: A cross-sectional survey.Skin Health Dis. 2024 Jun 15;4(5):e408. doi: 10.1002/ski2.408. eCollection 2024 Oct. Skin Health Dis. 2024. PMID: 39355722 Free PMC article.
-
Bidirectional Associations Between Mental Health Disorders and Chronic Diabetic Complications in Individuals With Type 1 or Type 2 Diabetes.Diabetes Care. 2024 Sep 1;47(9):1638-1646. doi: 10.2337/dc24-0818. Diabetes Care. 2024. PMID: 39008530
-
Anxiety symptoms predict head and neck cancer survival: Exploring mediation by systemic inflammation and tumor response to treatment.Psychooncology. 2024 Jul;33(7):e6375. doi: 10.1002/pon.6375. Psychooncology. 2024. PMID: 38987936
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
